logo
Plus   Neg
Share
Email

EMD, Pfizer Accept DMC Recommendation To Terminate Head And Neck Cancer Trial

EMD Serono, the biopharmaceutical business of Merck KGaA in the US and Canada, and Pfizer Inc. (PFE) said that they have accepted the recommendation of the independent Data Monitoring Committee or DMC to terminate the Phase III JAVELIN Head and Neck 100 trial. Because, the study did not show a statistically significant improvement in the primary endpoint of progression-free survival or PFS.

The study evaluated avelumab in addition to chemoradiotherapy (CRT) versus standard-of-care CRT in patients with untreated locally advanced squamous cell carcinoma of the head and neck.

Head and neck cancer is the sixth most common cancer worldwide. In 2016, there were nearly 150,000 newly diagnosed cases in the United States, Japan and Europe.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apotex Corp. recalled all lots of type 2 diabetes medication Metformin hydrochloride in the form of oral film-coated tablets for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA), above levels of the Acceptable Daily Intake Limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement. Groupe Renault plans to cut about 14,600 jobs across the world and lower its production capacity. The plan includes almost 4,600 jobs reduction in France, through voluntary retirement and retraining. Amazon said it will convert 125,000 of the 175,000 temporary workers it hired in March amid the coronavirus pandemic, to permanent full-time employees in June. The e-commerce giant had hired the temporary employees in March to meet strong consumer demand amid the lockdown. The job openings were in Amazon's fulfillment centers and its delivery network.
Follow RTT